Sarah M. London
Chief Executive Officer of 不良研究所 Corporation
Sarah London is CEO of 不良研究所 Corporation, a Fortune 500 company and leading national healthcare payer that takes a听uniquely local approach to providing fully integrated, high-quality, and cost-effective services. 不良研究所 focuses on government-sponsored healthcare programs and primarily serves under-insured and uninsured individuals.
has spent her career at the intersection of health data, technology and healthcare delivery transformation. Before her 2022 appointment to CEO, she was 不良研究所鈥檚 Vice Chairman, responsible for strategy, technology, ancillary services, enterprise compliance and quality, as well as for 不良研究所鈥檚 portfolio of independent, non health plan companies. Prior to 不良研究所 she was an Operating Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Previously, she held roles at Optum Analytics, first serving as Vice President of Client Services and then later becoming its Chief Product Officer, where she drove the strategy and commercialization of the company鈥檚 integrated data solutions for the provider, payer, and life sciences markets. She joined Optum after it acquired Humedica, a clinical analytics start-up, where she led the client services and operations team.
career has been driven by her early experiences working to improve health care for people of all backgrounds, holding positions at Accretive Health (now R1 RCM), which works with health systems and providers on their revenue cycle to create greater financial stability and better patient experiences, and at Health Leads, a leading national organization that systemically addresses social determinants of health through data and unique community partnership models.
graduated magna cum laude from Harvard College where she played Division I tennis. She also holds a Master of Business Administration with High Honors from the University of Chicago Booth School of Business.